China Longyuan Power Group Corporation (00916) completed a cumulative power generation of 56.2504 million MWh in the first nine months, a year-on-year decrease of 0.52%.
China Longyuan Power Group Corporation (00916) announced that in September 2026, the company completed power generation of 5.6666 million MWh on a consolidated basis, representing a year-on-year increase of 7.08% compared with the same period in 2025. This month, wind power generation increased by 3.20% year on year, and solar power generation increased by 20.21% year on year.
China Longyuan Power Group Corporation (00916) announced that in September 2026, the company completed power generation of 5.6666 million MWh on a consolidated basis, representing a year-on-year increase of 7.08% compared with the same period in 2025. This month, wind power generation increased by 3.20% year-on-year, and CECEP Solar Energy power generation increased by 20.21% year-on-year.
As of September 30, 2026, the company had completed a cumulative power generation of 56.2504 million MWh in 2026, representing a year-on-year decrease of 0.52% compared with the same period in 2025, of which wind power generation decreased by 4.97% year-on-year, while CECEP Solar Energy power generation increased by 19.29% year-on-year.
Related Articles

US Stock Market Move | U.S. clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) debuted on the U.S. stock market, with its share price falling more than 10% after the opening bell.

US Stock Market Move | Trex Bio (TRXB.US) debuts on the U.S. stock market, falling more than 1.3% after the open.

US Stock Market Move | Included in the Nasdaq 100 Index, Moderna (MRNA.US) rises 7%.
US Stock Market Move | U.S. clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) debuted on the U.S. stock market, with its share price falling more than 10% after the opening bell.

US Stock Market Move | Trex Bio (TRXB.US) debuts on the U.S. stock market, falling more than 1.3% after the open.

US Stock Market Move | Included in the Nasdaq 100 Index, Moderna (MRNA.US) rises 7%.






